^
Association details:
Evidence:
Evidence Level:
Sensitive: D – Preclinical
New
Title:

The Irreversible Covalent Fibroblast Growth Factor Receptor Inhibitor PRN1371 Exhibits Sustained Inhibition of FGFR after Drug Clearance

Excerpt:
Tumor-bearing mice were orally dosed with vehicle or PRN1371 at a dose of 15 mg/kg b.i.d. Significant tumor growth inhibition was observed in three of the four squamous NSCLC PDX models (Table 3).
DOI:
10.1158/1535-7163.MCT-17-0309